Researchers propose using combined Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) methods, specifically using the 5-HT2A-selective ligand [11 C]Cimbi-36, to create a 'molecular-functional-clinical bridge' in understanding psychedelic effects.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (3)

• PET concept
• Magnetic Resonance Imaging concept
• psychedelic effects concept